Merck Acquisition of Prometheus Biosciences 2023

Merck & Co., Inc. announced its acquisition of Prometheus Biosciences, effective April 17, 2023. The presentation covers the strategic rationale, scientific and clinical profiles, commercial opportunities, and financial overview of the transaction, subject to shareholder approval and regulatory clearance.